Oncology News | pharmaphorum

News

UK startup Leucid raises £11.5m for solid tumour CAR-T thera...

CAR-T therapies have revolutionised the treatment of some blood cancers, but so far haven't been able to repeat that success in solid tumours.

News

Good news for Lilly as sintilimab hits the spot in lung canc...

Eli Lilly made a late entry into the checkpoint inhibitor market when it licensed ex-China rights to Innovent's sintilimab last year, and a new trial in lung cancer will raise its hopes of

News

Roche scores adjuvant lung cancer approval for Tecentriq

Roche has claimed an earlier-than-expected FDA approval for its checkpoint inhibitor Tecentriq in non-small cell lung cancer (NSCLC), giving the drug a lead in early-stage cases that can be

News

Keytruda approved as first-line advanced cervical cancer the...

The FDA has approved Merck’s Keytruda as a first-line therapy for advanced cervical cancer.

News

FDA halts Allogene CAR-T trial after safety scare

A phase 1 trial of Allogene's of-the-shelf CAR-T for lymphoma has been placed on hold by the FDA, after a "chromosomal abnormality" was seen in a patient receiving the cell therapy.

News

Enhertu nabs speedy FDA review for earlier use in breast can...

Hard on the heels of impressive new data for Enhertu as a second-line therapy for breast cancer, AstraZeneca and Daiichi Sankyo have claimed FDA breakthrough status for the drug that should

UK startup Leucid raises £11.5m for solid tumour CAR-T thera...

Good news for Lilly as sintilimab hits the spot in lung canc...

Roche scores adjuvant lung cancer approval for Tecentriq

Keytruda approved as first-line advanced cervical cancer the...

FDA halts Allogene CAR-T trial after safety scare

Enhertu nabs speedy FDA review for earlier use in breast can...

FDA orders blindness risk warning to GLP-1 agonist labels

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks